Alembic snug after latest plant inspections, but street remains cautious
Updated : April 24, 2018 07:17 PM IST
Alembic’s active pharmaceutical ingredient (API) units in Panelav in Gujarat had successful back-to-back inspections by the USFDA.
But the company’s oral solid unit in Panelav, inspected by the USFDA in 2016 and 2018, didn’t enjoy the same zero observations as the API plants.
The stakes are even higher as the Panelav solid dosages plant is the only USFDA-approved formulation facility and the US contributes 28% of total sales.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more